Case number 1:17-cv-01830
Millennium Pharmaceuticals, Inc. v. Qilu Pharmaceutical Co., Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 30, 2019 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per the entry of the judgment in Lead Case No. 13-1874-CFC. (nmf) |
| Sep 20, 2018 | N/A | Case Reassigned to CFC (0) Docket Text: Case reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:12-cv-01490-CFC, 1:12-cv-01750-CFC, 1:13-cv-01874-CFC, 1:14-cv-00093-CFC, 1:16-cv-00223-CFC, 1:15-cv-00702-CFC, 1:17-cv-00422-CFC, 1:17-cv-00423-CFC, 1:16-cv-00998-CFC, 1:17-cv-01830-CFC (rjb) Modified on 9/20/2018 (rjb). |
| Sep 20, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: the previous entry reassigning this case to Judge Connolly had the incorrect Judge's initials in the text. Entries were corrected to reflect the below case numbers. Associated Cases: 1:12-cv-01490-CFC, 1:12-cv-01750-CFC, 1:13-cv-01874-CFC, 1:14-cv-00093-CFC, 1:16-cv-00223-CFC, 1:15-cv-00702-CFC, 1:17-cv-00422-CFC, 1:17-cv-00423-CFC, 1:16-cv-00998-CFC, 1:17-cv-01830-CFC (rjb) |
| Sep 20, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Pursuant to the reassignment of this action, the parties shall submit a joint status report on or before October 4, 2018. Please identify in the status report the next event the parties believe the Court needs to schedule. (Status report due 10/4/2018.) Ordered by Judge Colm F. Connolly on September 20, 2018. Associated Cases: 1:12-cv-01490-CFC et al.(nmf) |
| Mar 26, 2018 | N/A | Case Stayed (0) Docket Text: Case Stayed. Associated Cases: 1:15-cv-00702-GMS, 1:17-cv-01830-GMS(mdb) |
| Mar 14, 2018 | N/A | Remark (0) Docket Text: Remark - These cases have been consolidated for all purposes. All future filings shall be made ONLY in Lead C.A. No. 13-1874 (GMS). Associated Cases: 1:13-cv-01874-GMS et al.(mdb) |
| Mar 9, 2018 | 15 | Answer to Counterclaim (7) Docket Text: ANSWER to [11] Answer to Complaint, Counterclaim by Millennium Pharmaceuticals, Inc..(Noreika, Maryellen) |
| Mar 5, 2018 | 14 | Proposed Order (8) |
| Mar 5, 2018 | 14 | Letter to Judge Sleet from M. Noreika enclosing order (1) |
| Mar 5, 2018 | 14 | Main Document (8) Docket Text: PROPOSED ORDER -- Proposed Scheduling Order -- by Millennium Pharmaceuticals Inc., Millennium Pharmaceuticals, Inc.. (Attachments: # (1) Letter to Judge Sleet from M. Noreika enclosing order)(Noreika, Maryellen) |
| Feb 26, 2018 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Gregory M. Sleet - Telephone Scheduling Conference held on 2/26/2018. The parties propose to consolidate these cases for one trial. A 5-day Bench Trial is set for Monday, September 30, 2019 at 9:00 AM. A proposed amended scheduling order is due by Monday, March 5, 2018. (Court Reporter Kevin Maurer.) Associated Cases: 1:17-cv-00423-GMS et al.(mdb) |
| Feb 21, 2018 | 13 | Order (2) Docket Text: ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 2/21/2018. (asw) |
| Feb 20, 2018 | 11 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, Additional Defenses, COUNTERCLAIM against Millennium Pharmaceuticals, Inc. by Qilu Pharmaceutical Co., Ltd., Qilu Pharma Inc..(Ormerod, Eve) Modified on 2/21/2018 (mdb). |
| Feb 20, 2018 | 12 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent ShanDong Lufa Pharmaceutical Investment Co., Ltd. for Qilu Pharmaceutical Co., Ltd.; Corporate Parent Antibiotics Hong Kong International Limited for Qilu Pharma Inc. filed by Qilu Pharma Inc., Qilu Pharmaceutical Co., Ltd.. (Belgam, Neal) |
| Jan 10, 2018 | 10 | SO ORDERED (3) Docket Text: SO ORDERED - re (23 in 1:17-cv-00423-GMS) Stipulation Regarding Discovery and Further Scheduling Conference filed by Millennium Pharmaceuticals, Inc.. Signed by Judge Gregory M. Sleet on 1/10/2018. Associated Cases: 1:17-cv-00423-GMS et al. copied per paragraph 2 of this stipulation. (mdb) |
| Jan 9, 2018 | 6 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Qilu Pharmaceutical Co., Ltd. on 12/22/2017 by Millennium Pharmaceuticals, Inc.. Waiver of Service due by 1/22/2018. (Noreika, Maryellen) |
| Jan 9, 2018 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Millennium Pharmaceuticals, Inc.: For Qilu Pharmaceutical Co., Ltd. waiver sent on 12/22/2017, answer due 2/20/2018. (Noreika, Maryellen) |
| Jan 9, 2018 | 8 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Qilu Pharma Inc. on 12/22/2017 by Millennium Pharmaceuticals, Inc.. Waiver of Service due by 1/22/2018. (Noreika, Maryellen) |
| Jan 9, 2018 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Millennium Pharmaceuticals, Inc.: For Qilu Pharma Inc. waiver sent on 12/22/2017, answer due 2/20/2018. (Noreika, Maryellen) |
| Dec 27, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. (rjb) |
| Dec 20, 2017 | 1 | Complaint (13) |
| Dec 20, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Qilu Pharma Inc. on 12/20/2017; Qilu Pharmaceutical Co., Ltd. on 12/20/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmfn) |
| Dec 20, 2017 | 1 | Exhibits A & B (30) |
| Dec 20, 2017 | 1 | Civil Cover Sheet (1) |
| Dec 20, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmfn) |
| Dec 20, 2017 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/10/2017. Date of Expiration of Patent: 1/25/2022.Thirty Month Stay Deadline: 5/10/2020. (nmfn) |
| Dec 20, 2017 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,713,446 B2; 6,958,319 B2. (nmfn) |
| Dec 20, 2017 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceuticals Company Limited for Millennium Pharmaceuticals, Inc. filed by Millennium Pharmaceuticals, Inc. (nmfn) |
| Dec 20, 2017 | 1 | Main Document (13) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Qilu Pharma Inc., Qilu Pharmaceutical Co., Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2288699.) - filed by Millennium Pharmaceuticals, Inc. (Attachments: # (1) Exhibits A & B, # (2) Civil Cover Sheet)(nmfn) |
| Dec 20, 2017 | 1 | Complaint* (1) |
